Cyclopharm (ASX:CYC) Commences Patient Imaging in PRONOSPECT Trial
Cyclopharm (ASX: CYC) has commenced patient imaging for its Technegas in a pivotal French clinical trial aimed at pulmonary embolism diagnosis.
Cyclopharm (ASX: CYC) has commenced patient imaging for its Technegas in a pivotal French clinical trial aimed at pulmonary embolism diagnosis.
Collins Foods Limited announces its half-year financial results, reporting revenue growth but a decline in profit, and declares an interim dividend.
European Lithium Limited secures an EIA exemption, marking a significant milestone for the Wolfsberg Lithium Project in Austria.
RURAL FUNDS GROUP (ASX:RFF) announces a quarterly dividend distribution of AUD 0.02932500 per unit, payable on 31 January 2025.
Pro-Pac Packaging Limited (ASX:PPG) confirms discussions on funding arrangements following an ASX price query regarding recent trading activity.
Metcash Limited reports increased revenue and interim dividend in its FY25 Half Year Results, with strong performance across food and liquor segments.
Atturra Limited finalises the acquisition of Chrome Consulting, enhancing its enterprise content management capabilities.
Papyrus Australia Ltd (ASX:PPY) reports strong cash flow from operations, ending October 2024 with significant funding available for future activities.
Australian Pacific Coal Limited shares updates on Dartbrook operations, including new miners and upcoming coal sales.
Centuria Capital Group reported stable performance and future growth strategies during its 2024 AGM, showcasing resilience amidst economic challenges.